← Open Payments lookup

MARK HIGGINS: Open Payments

NPI 1134193469 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,181 in 190 payments from 28 companies in 2025. Trend: 2023 $4,495 · 2024 $6,034 · 2025 $4,181

Food & beverage: $4,181
CompanyPaymentsAmount
ViiV Healthcare Company41$692
Gilead Sciences, Inc.23$631
ABBVIE INC.21$413
EMD Serono, Inc.23$385
AstraZeneca Pharmaceuticals LP15$357
PFIZER INC.14$306
Merck Sharp & Dohme LLC7$196
Novo Nordisk Inc11$194
Axsome Therapeutics, Inc.1$138
Boston Scientific Corporation1$102

Products named: CABENUVA, AIRSUPRA, DOVATO, RUKOBIA, ELIQUIS, VIBERZI, Auvelity, VRAYLAR.

Industry payments across CA — which companies pay providers there.